Stay updated on Ciforadenant Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.

Latest updates to the Ciforadenant Safety and Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has been updated to include new information about the study of Ciforadenant in combination with Atezolizumab for Renal Cell Cancer, including details about the study's collaborators and the revision number. The previous detailed descriptions of the study's methodology and criteria have been removed.SummaryDifference26%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check115 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Ciforadenant Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.